Skip to main content
. 2017 Sep 19;12:6973–6984. doi: 10.2147/IJN.S139011

Figure 1.

Figure 1

Simulated diagram of the interaction of double-receptor-targeting IONPs conjugated with LHRH and AE105 peptides with a cancer cell.

Abbreviations: IONPs, iron oxide nanoparticles; LHRH, luteinizing hormone-releasing hormone receptor peptide; AE105, urokinase-type plasminogen activator receptor peptide; PTX, paclitaxel; uPAR, urokinase-type plasminogen activator receptor.